Levetiracetam [INN] en es it fr

Levetiracetam [INN] Brand names, Levetiracetam [INN] Analogs

Levetiracetam [INN] Brand Names Mixture

  • No information avaliable

Levetiracetam [INN] Chemical_Formula


Levetiracetam [INN] RX_link


Levetiracetam [INN] fda sheet

Levetiracetam_[INN] FDA

Levetiracetam [INN] msds (material safety sheet)

Levetiracetam_[INN] MSDS

Levetiracetam [INN] Synthesis Reference

No information avaliable

Levetiracetam [INN] Molecular Weight

650.974 g/mol

Levetiracetam [INN] Melting Point

236.5 oC

Levetiracetam [INN] H2O Solubility

3.96 mg/L

Levetiracetam [INN] State


Levetiracetam [INN] LogP


Levetiracetam [INN] Dosage Forms


Levetiracetam [INN] Indication

Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis.

Levetiracetam [INN] Pharmacology

Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) or triiodothyronine (T3, liothyronine) or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupling of the amino acid tyrosine. Liothyronine (T3) contains three atoms of iodine and is formed by the coupling of one molecule of diiodotyrosine (DIT) with one molecule of monoiodotyrosine (MIT). These hormones enhance oxygen consumption by most tissues of the body and increase the basal metabolic rate and the metabolism of carbohydrates, lipids and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system.

Levetiracetam [INN] Absorption

Almost totally absorbed, 95 percent in 4 hours.

Levetiracetam [INN] side effects and Toxicity

No information avaliable

Levetiracetam [INN] Patient Information

Levetiracetam [INN] Organisms Affected

Humans and other mammals